Skip to content

Author

Susanna Esposito

We have 9 of 116 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Maternal Immunization Against Respiratory Syncytial Virus: An Updated WAidid Consensus Document on Evidence, Implementation, and Public Health Priorities

Background: Respiratory syncytial virus (RSV) is a major cause of lower respiratory tract disease and hospitalization in early infancy. The availability of maternal RSVpreF vaccination and long-acting infant monoclonal antibodies has created two effective but operationally distinct pathways for passive protection. Meth...

Susanna Esposito, Matteo Riccò, B. Abu-Raya et al. · 0 citations
Review Aug 2026

Early-life respiratory infections and their association with chronic lung disease: an expert perspective.

INTRODUCTION Early-life respiratory infections may disrupt lung development during critical fetal, neonatal, and infant windows, when alveolarization, airway and vascular maturation, and immune programming remain active, potentially causing effects beyond the acute illness. AREAS COVERED This narrative review examine...

Susanna Esposito, Valentina Fainardi, N. Principi · 0 citations
Review Open access Aug 2026

Telemedicine in Pediatric Cardiology: Current Applications, Clinical Impact, and Future Perspectives

Challenges remain, including data fragmentation, limited pediatric validation of consumer devices, interoperability issues, privacy concerns, and socioeconomic disparities in technology access, but properly integrated telemedicine may promote more timely, equitable, and patient-centered Pediatrics.

L. Rizzo, Matilde Petz, Federico Carlini et al. · 0 citations
Review Open access Sep 2026

Human metapneumovirus prevention in children: emerging roles of monoclonal antibodies and vaccines

Human metapneumovirus (hMPV) is a major cause of acute lower respiratory tract infection in children, older adults, and individuals with underlying medical conditions. In pediatric populations, hMPV contributes substantially to hospitalizations, morbidity, and healthcare costs, yet no licensed vaccine or monoclonal ant...

Susanna Esposito, Valentina Fainardi, Gaia Giorgia Arnesano et al. · 0 citations
Review Open access Sep 2026

Antibiotic Therapy in Acute Infectious Diarrhea and Clostridioides difficile Infection: Clinical Indications, Antimicrobial Stewardship, and Evidence Gaps

Background: Most acute gastrointestinal infections are self-limiting, but antibiotics remain essential for selected patients with severe, invasive, or high-risk disease. This narrative review examines when antibiotics should be started or withheld in adults and children with suspected or confirmed bacterial gastrointes...

Roberta Rotondo, Piera Cicchetti, Serena Olivelli et al. · 0 citations
Review Open access Oct 2026

Artificial Intelligence in the Fight Against Antimicrobial Resistance: Applications in Diagnosis, Susceptibility Prediction, Precision Dosing, and Antibiotic Discovery

Background: Antimicrobial resistance (AMR) is a major global health threat, while conventional diagnostic, stewardship, dosing, and drug-development strategies remain limited by diagnostic delays, population-level decision-making, and a shrinking antibiotic pipeline. Artificial intelligence (AI) may help address these...

Susanna Esposito, Valentina Fainardi, Gaia Giorgia Arnesano et al. · 0 citations
Open access Sep 2026

Pediatric pseudotumor cerebri syndrome: Clinical characteristics, management and outcomes in a single-center cohort.

OBJECTIVE Pediatric pseudotumor cerebri syndrome (PTCS) differs from adult disease in epidemiology, risk factors and clinical presentation. Female predominance and obesity are typically reported after puberty, while secondary forms are more frequent in younger children. Due to limited data on prepubertal patients, this...

Angelica De Luisa, L. Caiazza, M. Gnazzo et al. · 0 citations
Review Open access Aug 2026

Dengue Vaccines in a Changing Epidemiological Landscape: Current Evidence, Unresolved Challenges, and Public Health Considerations

Background: Dengue has expanded rapidly beyond traditional tropical and subtropical regions, driven by climate change, urbanization, population mobility, and the spread of competent Aedes vectors. Vaccination is an increasingly important component of dengue prevention, but development has been complicated by four viral...

Susanna Esposito, N. Principi · 0 citations
Open access Aug 2026

Impact on Pediatric Respiratory Virus Epidemiology Following Nirsevimab Introduction.

Following nirsevimab introduction, pediatric ARI hospitalizations declined without evidence of viral replacement and the selective reduction in RSV coinfections suggests that RSV prevention may reduce infection complexity in addition to RSV-associated disease.

C. di Chiara, Vera Rigamonti, B. Campana et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.